Noninvasive disease monitoring and risk stratification by circulating tumor DNA (ctDNA)
profiling has become a potential novel strategy for patient management in B-cell lymphoma …

Objectives The diagnostic workup of lymphoma continues to evolve rapidly as experience
and discovery lead to the addition of new clinicopathologic entities and techniques to …

Flow cytometry (FC) has a well‐established role in the diagnostic evaluation of mature B‐
cell neoplasms. Effective assessment for lineage associated antigens, aberrant antigen …

Moreau score has been used to differentiate chronic lymphocytic leukemia (CLL) from other
mature B‐cell neoplasms. However, it showed limitations in Asian patients. Therefore, we …

Circulating tumour DNA (ctDNA) is a highly versatile analyte and an emerging biomarker for
detection of tumour‐specific sequences in lymphoid malignancies. Since ctDNA is derived …

Central nervous system (CNS) involvement by lymphoid neoplasms is a relatively infrequent
event that demands accurate identification. The purpose of this article is to review studies …

Introduction Infiltration of the central nervous system (CNS) by hematologic or lymphoid
malignant cells can cause extensive neurological damage, be progressive and fatal …

Background Secondary central nervous system lymphoma (SCNSL) is a rare and
aggressive disease, which is defined as secondary central nervous system (CNS) …

High-throughput single-cell technologies have recently emerged as essential tools in
biomedical research with great potential for clinical pathology when studying liquid and solid …

Background Neoplastic meningitis is a complication of solid and hematological
malignancies. It consists of the spread of malignant cells to the leptomeninges and …